Please assess the completion status of the following clinical trial:

Trial Title: Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with Type 2 diabetes~* Treatment with metformin at a stable dose \>1500 mg/day~* HbA1c ≥ 7.0% and ≤10.0%~Exclusion Criteria:~* Insulin therapy within one year of enrolment (with the exception of insulin therapy during a hospitalization or use in gestational diabetes)~* Type 1 diabetes, history of ketoacidosis, or hyperosmolar non-ketonic koma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Metformin + Saxagliptin
- 2 (Type: PLACEBO_COMPARATOR): Metformin + Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).